rs2282983

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001145306.2(CDK6):​c.647+21377A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.433 in 152,048 control chromosomes in the GnomAD database, including 14,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).

Frequency

Genomes: 𝑓 0.43 ( 14933 hom., cov: 32)

Consequence

CDK6
NM_001145306.2 intron

Scores

2

Clinical Significance

association no assertion criteria provided O:1

Conservation

PhyloP100: -1.03

Publications

10 publications found
Variant links:
Genes affected
CDK6 (HGNC:1777): (cyclin dependent kinase 6) The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]
CDK6 Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microcephaly 12, primary, autosomal recessive
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.572 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK6NM_001145306.2 linkc.647+21377A>G intron_variant Intron 5 of 7 ENST00000424848.3 NP_001138778.1
LOC112268009XR_002956577.2 linkn.12622A>G non_coding_transcript_exon_variant Exon 1 of 2
CDK6NM_001259.8 linkc.647+21377A>G intron_variant Intron 5 of 7 NP_001250.1
CDK6XM_047419716.1 linkc.647+21377A>G intron_variant Intron 5 of 7 XP_047275672.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK6ENST00000424848.3 linkc.647+21377A>G intron_variant Intron 5 of 7 1 NM_001145306.2 ENSP00000397087.3
CDK6ENST00000265734.8 linkc.647+21377A>G intron_variant Intron 5 of 7 1 ENSP00000265734.4
ENSG00000286742ENST00000668236.1 linkn.113+2031T>C intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.433
AC:
65731
AN:
151932
Hom.:
14909
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.578
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.436
Gnomad ASJ
AF:
0.465
Gnomad EAS
AF:
0.273
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.381
Gnomad MID
AF:
0.509
Gnomad NFE
AF:
0.366
Gnomad OTH
AF:
0.433
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.433
AC:
65815
AN:
152048
Hom.:
14933
Cov.:
32
AF XY:
0.436
AC XY:
32360
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.578
AC:
23970
AN:
41470
American (AMR)
AF:
0.436
AC:
6664
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.465
AC:
1612
AN:
3470
East Asian (EAS)
AF:
0.274
AC:
1415
AN:
5172
South Asian (SAS)
AF:
0.385
AC:
1857
AN:
4824
European-Finnish (FIN)
AF:
0.381
AC:
4027
AN:
10560
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.366
AC:
24862
AN:
67958
Other (OTH)
AF:
0.437
AC:
922
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1869
3739
5608
7478
9347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.394
Hom.:
34643
Bravo
AF:
0.443
Asia WGS
AF:
0.404
AC:
1405
AN:
3476

ClinVar

Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Behcet disease Other:1
Nov 14, 2021
Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
11
DANN
Benign
0.71
PhyloP100
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2282983; hg19: chr7-92279363; API